AMERICAN CRYOSTEM CRYO news, videos and press releases
For more news please use our advanced search feature.
AMERICAN CRYOSTEM CRYO - More news...
AMERICAN CRYOSTEM CRYO - More news...
- American CryoStem Announces Patient Treatment Status for its Phase I Clinical Trial for Post-Concussion Syndrome (PCS)
- American CryoStem Announces Completion of Patient Recruitment for its Post-Concussion Syndrome (PCS) ATCELL(TM) Phase I Clinical Trial
- American CryoStem Completes Clinical Protocol Design for Long COVID Study
- American CryoStem Announces the Addition of John Schwartz, PhD to Its Advisory Board
- American CryoStem to Study New Standardized Treatment Protocols for Wound Healing
- American CryoStem Enters into an Agreement to Exchange Shares held by ACS Global, Inc
- American CryoStem Executes LOI with Advanced Regenerative Associates to Conduct Wound Healing Clinical Study
- American CryoStem Announces Patient Biomaterial Processing for its Post-Concussion Syndrome (PCS) Phase I Clinical Trial
- American CryoStem and BioTherapeutic Labs Corp. Enter into R&D, Collaboration and Marketing Agreement
- American CryoStem Enters into a Cooperative Research and Development Agreement (CRADA) to Develop Standardized Treatment Protocols
- American CryoStem Announces Patient Recruitment and Additional Sub-Investigator for its Post-Concussion Syndrome (PCS) Phase I Clinical Trial
- American CryoStem Announces: FDA has cleared its Investigational New Drug (IND) for Post-Concussion Syndrome for Phase I Clinical Trial
- American CryoStem Issues Shareholder Update Letter
- American CryoStem Announces the Conversion of Debenture into Equity and Sale into the Market
- American CryoStem to Develop ATCELL(TM) Clinical Study for Duchene Muscular Dystrophy with RACEMD
- American CryoStem Expands Investigator Team with Sub-Investigators for Post Concussive Syndrome IND
- American CryoStem Announces: FDA Accepted its Investigational New Drug Application for Post Concussion Syndrome
- American CryoStem Engages BioSolutions Clinical Research Center, LLC. and Principal Investigator for Chronic Concussive Syndrome IND
- American CryoStem Engages IRB for IND Filling with the FDA
- American CryoStem Completes Cooperative Framework Agreement to Expand Market Presence in Japan
- American CryoStem to file Investigational New Drug Application with FDA
- American CryoStem Receives Final Patent to Complete its Core Cellular Platform
- American CryoStem Announces Receipt of Key Business Method Patent for its Cellular Platform
- American CryoStem Announces Launch of ATGRAFT(TM) in China
- American CryoStem to Develop Standardized Tissue Scoring System
- American CryoStem to Exhibit at The Aesthetic Meeting 2018 in New York, NY
- Cryo Announces Notice of Allowance of Claims for Its Core Patent
- American Cryostem Corporation 2017 Year End Update
- American CryoStem Statement on the Receipt of a Warning Letter from FDA
- American CryoStem Secures a Major Contract in Mainland China